Butanediol Conversion to Gamma‐Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole
- Liakoni, Evangelia Clinical Pharmacology and ToxicologyDepartment of General Internal Medicine, InselspitalBern University HospitalUniversity of Bern Bern Switzerland
- Gugelmann, Hallam California Poison Control CenterUniversity of California San Francisco California USA
- Dempsey, Delia A. Division of Clinical Pharmacology and Experimental TherapeuticsDepartment of MedicineUniversity of California San Francisco California USA
- Wiegand, Timothy J. University of Rochester Medical Center Rochester New York USA
- Havel, Christopher Division of Clinical Pharmacology and Experimental TherapeuticsDepartment of MedicineUniversity of California San Francisco California USA
- Jacob, Peyton Division of Clinical Pharmacology and Experimental TherapeuticsDepartment of MedicineUniversity of California San Francisco California USA
- Benowitz, Neal L. Department of Bioengineering and Therapeutic SciencesUniversity of California San Francisco California USA
- 2019-1-8
Published in:
- Clinical Pharmacology & Therapeutics. - Wiley. - 2019, vol. 105, no. 5, p. 1196-1203
- Language
-
- English
- Open access status
- green
- Identifiers
-
- DOI 10.1002/cpt.1306
- ISSN 0009-9236
- Persistent URL
- https://sonar.ch/global/documents/34662
Statistics
Document views: 36
File downloads:
- Full-text: 0